# Natures Sunshine Products Inc: financial statements, quarterly

NATR · Nasdaq · CIK 275053 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/natr.md) · [Financials](/companies/natr/financials.md) · [Filings](/companies/natr/filings.md) · [Insiders](/companies/natr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/natr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [111](/filings/0001628280-24-046400.md) | [109 d](/filings/0001628280-25-012082.md) | [111](/filings/0001628280-25-022765.md) | [111](/filings/0001628280-25-037065.md) | [115](/filings/0000275053-25-000004.md) | [118 d](/filings/0001628280-26-016540.md) | [113](/filings/0001628280-26-032316.md) | [115](/filings/0001628280-26-054468.md) | [128](/filings/0000275053-25-000004.md) | [124 d](/filings/0001628280-26-016540.md) | [123](/filings/0001628280-26-032316.md) | [117](/filings/0001628280-26-054468.md) |
| Cost of revenue | $m | [30.0](/filings/0001628280-24-046400.md) | [30.6 d](/filings/0001628280-25-012082.md) | [32.0](/filings/0001628280-25-022765.md) | [31.7](/filings/0001628280-25-037065.md) | [32.9](/filings/0000275053-25-000004.md) | [33.1 d](/filings/0001628280-26-016540.md) | [31.7](/filings/0001628280-26-032316.md) | [32.5](/filings/0001628280-26-054468.md) | [34.3](/filings/0000275053-25-000004.md) | [34.0 d](/filings/0001628280-26-016540.md) | [32.9](/filings/0001628280-26-032316.md) | [30.8](/filings/0001628280-26-054468.md) |
| Gross profit | $m | [81.2](/filings/0001628280-24-046400.md) | [78.3 d](/filings/0001628280-25-012082.md) | [79.0](/filings/0001628280-25-022765.md) | [78.9](/filings/0001628280-25-037065.md) | [81.8](/filings/0000275053-25-000004.md) | [85.1 d](/filings/0001628280-26-016540.md) | [81.6](/filings/0001628280-26-032316.md) | [82.3](/filings/0001628280-26-054468.md) | [94.0](/filings/0000275053-25-000004.md) | [89.8 d](/filings/0001628280-26-016540.md) | [90.0](/filings/0001628280-26-032316.md) | [86.2](/filings/0001628280-26-054468.md) |
| Selling, general and administrative | $m | [41.3](/filings/0001628280-24-046400.md) | [39.9 d](/filings/0001628280-25-012082.md) | [40.8](/filings/0001628280-25-022765.md) | [38.6](/filings/0001628280-25-037065.md) | [41.0](/filings/0000275053-25-000004.md) | [43.7 d](/filings/0001628280-26-016540.md) | [40.6](/filings/0001628280-26-032316.md) | [43.7](/filings/0001628280-26-054468.md) | [45.7](/filings/0000275053-25-000004.md) | [48.4 d](/filings/0001628280-26-016540.md) | [43.5](/filings/0001628280-26-032316.md) | [44.9](/filings/0001628280-26-054468.md) |
| Operating income | $m | [5.8](/filings/0001628280-24-046400.md) | [5.7 d](/filings/0001628280-25-012082.md) | [4.6](/filings/0001628280-25-022765.md) | [5.6](/filings/0001628280-25-037065.md) | [5.3](/filings/0000275053-25-000004.md) | [4.6 d](/filings/0001628280-26-016540.md) | [6.2](/filings/0001628280-26-032316.md) | [4.3](/filings/0001628280-26-054468.md) | [9.0](/filings/0000275053-25-000004.md) | [5.3 d](/filings/0001628280-26-016540.md) | [9.5](/filings/0001628280-26-032316.md) | [5.5](/filings/0001628280-26-054468.md) |
| Interest expense | $m | not reported | not reported | [0.0](/filings/0001628280-25-022765.md) | [0.1](/filings/0001628280-25-037065.md) | [0.0](/filings/0000275053-25-000004.md) | [0.0 d](/filings/0001628280-26-016540.md) | [0.0](/filings/0001628280-26-032316.md) | [0.0](/filings/0001628280-26-054468.md) | [0.0](/filings/0000275053-25-000004.md) | [0.0 d](/filings/0001628280-26-016540.md) | [0.0](/filings/0001628280-26-032316.md) | [0.1](/filings/0001628280-26-054468.md) |
| Income tax | $m | [1.8](/filings/0001628280-24-046400.md) | [(1.7) d](/filings/0001628280-25-012082.md) | [2.2](/filings/0001628280-25-022765.md) | [2.9](/filings/0001628280-25-037065.md) | [3.3](/filings/0000275053-25-000004.md) | [2.2 d](/filings/0001628280-26-016540.md) | [2.2](/filings/0001628280-26-032316.md) | [2.0](/filings/0001628280-26-054468.md) | [4.1](/filings/0000275053-25-000004.md) | [1.0 d](/filings/0001628280-26-016540.md) | [3.0](/filings/0001628280-26-032316.md) | [1.8](/filings/0001628280-26-054468.md) |
| Net income | $m | [2.8](/filings/0001628280-24-046400.md) | [9.0 d](/filings/0001628280-25-012082.md) | [2.3](/filings/0001628280-25-022765.md) | [1.3](/filings/0001628280-25-037065.md) | [4.3](/filings/0000275053-25-000004.md) | [(0.3) d](/filings/0001628280-26-016540.md) | [4.7](/filings/0001628280-26-032316.md) | [5.3](/filings/0001628280-26-054468.md) | [5.3](/filings/0000275053-25-000004.md) | [4.1 d](/filings/0001628280-26-016540.md) | [5.1](/filings/0001628280-26-032316.md) | [3.5](/filings/0001628280-26-054468.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001628280-24-046400.md) | not reported | [0.12](/filings/0001628280-25-022765.md) | [0.07](/filings/0001628280-25-037065.md) | [0.23](/filings/0000275053-25-000004.md) | not reported | [0.25](/filings/0001628280-26-032316.md) | [0.28](/filings/0001628280-26-054468.md) | [0.30](/filings/0000275053-25-000004.md) | not reported | [0.29](/filings/0001628280-26-032316.md) | [0.19](/filings/0001628280-26-054468.md) |
| Basic EPS | $ per share | [0.15](/filings/0001628280-24-046400.md) | not reported | [0.12](/filings/0001628280-25-022765.md) | [0.07](/filings/0001628280-25-037065.md) | [0.23](/filings/0000275053-25-000004.md) | not reported | [0.26](/filings/0001628280-26-032316.md) | [0.29](/filings/0001628280-26-054468.md) | [0.30](/filings/0000275053-25-000004.md) | not reported | [0.29](/filings/0001628280-26-032316.md) | [0.20](/filings/0001628280-26-054468.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [76.0](/filings/0001628280-23-037442.md) | [82.4](/filings/0001628280-25-012082.md) | [77.8](/filings/0001628280-24-021178.md) | [68.7](/filings/0001628280-24-036235.md) | [78.7](/filings/0001628280-24-046400.md) | [84.7](/filings/0001628280-26-016540.md) | [86.5](/filings/0001628280-25-022765.md) | [81.3](/filings/0001628280-25-037065.md) | [95.6](/filings/0000275053-25-000004.md) | [93.9](/filings/0001628280-26-054468.md) | [87.6](/filings/0001628280-26-032316.md) | [82.5](/filings/0001628280-26-054468.md) |
| Current assets | $m | [160](/filings/0001628280-23-037442.md) | [166](/filings/0001628280-25-012082.md) | [160](/filings/0001628280-24-021178.md) | [152](/filings/0001628280-24-036235.md) | [164](/filings/0001628280-24-046400.md) | [161](/filings/0001628280-26-016540.md) | [171](/filings/0001628280-25-022765.md) | [172](/filings/0001628280-25-037065.md) | [186](/filings/0000275053-25-000004.md) | [179](/filings/0001628280-26-054468.md) | [179](/filings/0001628280-26-032316.md) | [178](/filings/0001628280-26-054468.md) |
| Total assets | $m | [240](/filings/0001628280-23-037442.md) | [250](/filings/0001628280-25-012082.md) | [247](/filings/0001628280-24-021178.md) | [236](/filings/0001628280-24-036235.md) | [245](/filings/0001628280-24-046400.md) | [241](/filings/0001628280-26-016540.md) | [253](/filings/0001628280-25-022765.md) | [255](/filings/0001628280-25-037065.md) | [265](/filings/0000275053-25-000004.md) | [261](/filings/0001628280-26-054468.md) | [261](/filings/0001628280-26-032316.md) | [260](/filings/0001628280-26-054468.md) |
| Current liabilities | $m | [73.3](/filings/0001628280-23-037442.md) | [76.8](/filings/0001628280-25-012082.md) | [68.9](/filings/0001628280-24-021178.md) | [63.6](/filings/0001628280-24-036235.md) | [67.2](/filings/0001628280-24-046400.md) | [65.7](/filings/0001628280-26-016540.md) | [70.7](/filings/0001628280-25-022765.md) | [75.9](/filings/0001628280-25-037065.md) | [83.6](/filings/0000275053-25-000004.md) | [78.5](/filings/0001628280-26-054468.md) | [71.4](/filings/0001628280-26-032316.md) | [68.7](/filings/0001628280-26-054468.md) |
| Total liabilities | $m | [87.9](/filings/0001628280-23-037442.md) | [90.2](/filings/0001628280-25-012082.md) | [87.6](/filings/0001628280-24-021178.md) | [79.4](/filings/0001628280-24-036235.md) | [82.7](/filings/0001628280-24-046400.md) | [79.9](/filings/0001628280-26-016540.md) | [85.6](/filings/0001628280-25-022765.md) | [91.2](/filings/0001628280-25-037065.md) | [98.1](/filings/0000275053-25-000004.md) | [99.6](/filings/0001628280-26-054468.md) | [94.5](/filings/0001628280-26-032316.md) | [90.5](/filings/0001628280-26-054468.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001628280-24-021178.md) | [2.1](/filings/0001628280-24-021178.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | [0.0](/filings/0001628280-24-010625.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [152](/filings/0001628280-24-046400.md) | [160](/filings/0001628280-26-016540.md) | [160](/filings/0000275053-25-000004.md) | [156](/filings/0000275053-25-000004.md) | [163](/filings/0000275053-25-000004.md) | [161](/filings/0001628280-26-054468.md) | [167](/filings/0001628280-26-054468.md) | [164](/filings/0001628280-26-054468.md) | [167](/filings/0000275053-25-000004.md) | [162](/filings/0001628280-26-054468.md) | [167](/filings/0001628280-26-054468.md) | [169](/filings/0001628280-26-054468.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.4 d](/filings/0001628280-24-046400.md) | [9.6 d](/filings/0001628280-25-012082.md) | [2.2](/filings/0001628280-25-022765.md) | [1.3 d](/filings/0001628280-25-037065.md) | [9.6 d](/filings/0000275053-25-000004.md) | [12.2 d](/filings/0001628280-26-016540.md) | [2.6](/filings/0001628280-26-032316.md) | [4.3 d](/filings/0001628280-26-054468.md) | [18.5 d](/filings/0000275053-25-000004.md) | [9.9 d](/filings/0001628280-26-016540.md) | [(1.8)](/filings/0001628280-26-032316.md) | [0.8 d](/filings/0001628280-26-054468.md) |
| Capital expenditure | $m | [4.5 d](/filings/0001628280-24-046400.md) | [1.2 d](/filings/0001628280-25-012082.md) | [3.7](/filings/0001628280-25-022765.md) | [3.4 d](/filings/0001628280-25-037065.md) | [1.7 d](/filings/0000275053-25-000004.md) | [2.2 d](/filings/0001628280-26-016540.md) | [1.1](/filings/0001628280-26-032316.md) | [1.4 d](/filings/0001628280-26-054468.md) | [1.7 d](/filings/0000275053-25-000004.md) | [2.3 d](/filings/0001628280-26-016540.md) | [2.5](/filings/0001628280-26-032316.md) | [2.8 d](/filings/0001628280-26-054468.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [1.3 d](/filings/0001628280-24-046400.md) | [4.2 d](/filings/0001628280-25-012082.md) | [1.8](/filings/0001628280-25-022765.md) | [5.9 d](/filings/0001628280-25-037065.md) | [0.7 d](/filings/0000275053-25-000004.md) | [0.4 d](/filings/0001628280-26-016540.md) | [0.5](/filings/0001628280-26-032316.md) | [11.9 d](/filings/0001628280-26-054468.md) | [2.0 d](/filings/0000275053-25-000004.md) | [1.9 d](/filings/0001628280-26-016540.md) | [0.5](/filings/0001628280-26-032316.md) | [2.1 d](/filings/0001628280-26-054468.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.5](/filings/0001628280-23-037442.md) | [19.4](/filings/0001628280-24-021178.md) | [19.7](/filings/0001628280-24-036235.md) | [19.5](/filings/0001628280-24-046400.md) | [19.2](/filings/0001628280-25-022765.md) | [19.1](/filings/0001628280-25-037065.md) | [18.9](/filings/0000275053-25-000004.md) | [18.8](/filings/0001628280-26-032316.md) | [19.0](/filings/0001628280-26-054468.md) | [18.0](/filings/0000275053-25-000004.md) | [17.9](/filings/0001628280-26-032316.md) | [18.3](/filings/0001628280-26-054468.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,595,520 at 2026-07-24, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054468.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.